Atlas Trials

Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer

Clinical trial NCT02358473 · COMPLETED

Trial details

NCT number
NCT02358473
Sponsor
Kyowa Kirin, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2015-01-01
Primary completion
2016-12-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.